Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

被引:525
作者
Paul, Mical [1 ]
Shani, Vered [2 ]
Muchtar, Eli [2 ]
Kariv, Galia [2 ]
Robenshtok, Eyal [2 ]
Leibovici, Leonard [2 ]
机构
[1] Tel Aviv Univ, Infect Dis Unit, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Beilinson Hosp, Rabin Med Ctr,Dept Med E, IL-69978 Tel Aviv, Israel
关键词
VENTILATOR-ASSOCIATED PNEUMONIA; GRAM-NEGATIVE BACTEREMIA; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; AMINOGLYCOSIDE COMBINATION THERAPY; STAPHYLOCOCCUS-AUREUS BACTEREMIA; COMMUNITY-ACQUIRED BACTEREMIA; INITIAL ANTIMICROBIAL THERAPY; ACUTE MYOCARDIAL-INFARCTION; BETA-LACTAM MONOTHERAPY;
D O I
10.1128/AAC.00627-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Quantifying the benefit of early antibiotic treatment is crucial for decision making and can be assessed only in observational studies. We performed a systematic review of prospective studies reporting the effect of appropriate empirical antibiotic treatment on all-cause mortality among adult inpatients with sepsis. Two reviewers independently extracted data. Risk of bias was assessed using the Newcastle-Ottawa score. We calculated unadjusted odds ratios (ORs) with 95% confidence intervals for each study and extracted adjusted ORs, with variance, methods, and covariates being used for adjustment. ORs were pooled using random-effects meta-analysis. We examined the effects of methodological and clinical confounders on results through subgroup analysis or mixed-effect meta-regression. Seventy studies were included, of which 48 provided an adjusted OR for inappropriate empirical antibiotic treatment. Inappropriate empirical antibiotic treatment was associated with significantly higher mortality in the unadjusted and adjusted comparisons, with considerable heterogeneity occurring in both analyses (I-2 > 70%). Study design, time of mortality assessment, the reporting methods of the multivariable models, and the covariates used for adjustment were significantly associated with effect size. Septic shock was the only clinical variable significantly affecting results (it was associated with higher ORs). Studies adjusting for background conditions and sepsis severity reported a pooled adjusted OR of 1.60 (95% confidence interval = 1.37 to 1.86; 26 studies; number needed to treat to prevent one fatal outcome, 10 patients [95% confidence interval = 8 to 15]; I-2 = 46.3%) given 34% mortality with inappropriate empirical treatment. Appropriate empirical antibiotic treatment is associated with a significant reduction in all-cause mortality. However, the methods used in the observational studies significantly affect the effect size reported. Methods of observational studies assessing the effects of antibiotic treatment should be improved and standardized.
引用
收藏
页码:4851 / 4863
页数:13
相关论文
共 99 条
  • [1] Al-Reesi A, 2008, CAN J EMERG MED, V10, P215
  • [2] Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    AlvarezLerma, F
    Pellus, AM
    Sanchez, BA
    Ortiz, EP
    Jorda, R
    Barcenilla, F
    Maravi, E
    Galvan, B
    Palomar, M
    Serra, J
    Bermejo, B
    Mateu, A
    Quintana, E
    Palacios, MS
    Giral, R
    Gonzalez, V
    Lerma, FA
    Mesa, JL
    Melgarejo, JA
    Martinez, J
    Insausti, J
    Olaechea, P
    Chanovas, M
    Gilabert, A
    Junquera, C
    Valles, J
    Palacios, F
    Calvo, R
    Mesalles, E
    Nava, J
    Santos, A
    Armengol, S
    Marzo, D
    [J]. INTENSIVE CARE MEDICINE, 1996, 22 (05) : 387 - 394
  • [3] Epidemiology of sepsis in the Valencian Community (Spain), 1995-2004
    Andreu Ballester, Juan Carlos
    Ballester, Ferran
    Gonzalez Sanchez, Antonio
    Almela Quilis, Amadeo
    Colomer Rubio, Enrique
    Penarroja Otero, Carlos
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (07) : 630 - 634
  • [4] [Anonymous], 1988, LANCET, V2, P349
  • [5] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [6] Influence of antimicrobial treatment on mortality in septicemia
    Behrendt, G
    Schneider, S
    Brodt, HR
    Just-Nübling, G
    Shah, PM
    [J]. JOURNAL OF CHEMOTHERAPY, 1999, 11 (03) : 179 - 186
  • [7] Antibiotic prescription for community-acquired pneumonia in the intensive care unit:: Impact of adherence to Infectious Diseases Society of America guidelines on survival
    Bodí, M
    Rodríguez, A
    Solé-Violán, J
    Gilavert, MC
    Garnacho, J
    Blanquer, J
    Jimenez, J
    de la Torre, MV
    Sirvent, JM
    Almirall, J
    Doblas, A
    Badía, JR
    García, F
    Mendia, A
    Jordá, R
    Bobillo, F
    Vallés, J
    Broch, MJ
    Carrasco, N
    Herranz, MA
    Rello, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (12) : 1709 - 1716
  • [8] The spectrum of practice in the diagnosis and management of pneumonia in patients requiring mechanical ventilation. Australian and New Zealand practice in intensive care (ANZPIC II)
    Boots, RJ
    Lipman, J
    Bellomo, R
    Stephens, D
    Heller, RE
    [J]. ANAESTHESIA AND INTENSIVE CARE, 2005, 33 (01) : 87 - 100
  • [9] Bloodstream infections:: A trial of the impact of different methods of reporting positive blood culture results
    Bouza, E
    Sousa, D
    Muñoz, P
    Rodríguez-Créixems, M
    Fron, C
    Lechuz, JG
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) : 1161 - 1169
  • [10] BRYAN CS, 1983, REV INFECT DIS, V5, P629